| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701329 | European Journal of Surgical Oncology (EJSO) | 2016 | 7 Pages |
Abstract
No benefit was found of adding oxaliplatin in terms of CRM nor pCR rates for either concomitant or sequential settings in preoperative radiochemotherapy for very advanced rectal cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K. WiÅniowska, A. Nasierowska-Guttmejer, W. Polkowski, W. Michalski, L. Wyrwicz, L. Pietrzak, A. Rutkowski, M. Malinowska, J. KryÅski, E. Kosakowska, J. ZwoliÅski, M. Winiarek, J. OlÄdzki, J. KuÅnierz, L. ZajÄ
c, M. Bednarczyk, M. Szczepkowski,